Swedish News Blog

SNI Research Aims to Expand Cerebral Palsy Therapy Options

Angeli Mayadev, MD

Angeli Mayadev, MD
Physical Medicine & Rehabilitation, Swedish Multiple Sclerosis Center

Before they learn to crawl or walk, about 10,000 babies every year in the United States will develop a condition that will change how they will do just that. Cerebral palsy (CP) is a neurological condition caused by a brain injury before birth, during delivery or before a child’s second birthday. An estimated 800,000 Americans live with CP.

The most common symptom in CP is spasticity, an increase in muscle tension that impairs proper movement. Abnormal postures or movements, weakness or loss of muscle control and rigidity are also part of the constellation of CP signs and symptoms. While physical therapy remains the cornerstone for treatment, new medications and therapies for CP are being developed to help improve and manage symptoms.

Currently, Swedish Neuroscience Institute is participating in a study to determine the safety and tolerability of one such medication. Dalfampridine (AMPYRA ®) is a medication currently used to help improve walking speed in multiple sclerosis (MS) patients. This phase I clinical trial aims to evaluate AMPYRA’s® safety, tolerability and its effect on sensorimotor function of adults with CP. The study will look at how single and multiple doses of the medication have on CP patients, including:

  • Hand strength
  • Manual dexterity
  • Walking speed
  • Gait

There is no cure for cerebral palsy. Therapies for CP ...

Swedish Foundation Raises $100 Million to Help Meet Increasing Demand for Regional Health-Care Services

Swedish News

SEATTLE, Oct. 26, 2012 – Swedish Medical Center's seven-year fund-raising initiative, called The Campaign for Swedish, has raised $103 million, exceeding its initial $100 million fund-raising goal in approximately five-and-a-half years. The Campaign, launched to help improve patient care and treatment options throughout the Swedish system, is the largest fund-raising effort undertaken by the private, non-profit health system to date.

Swedish to Host Live Stream of Woman’s First Time Hearing in Five Years, Plus Live Text Chats

Swedish News

CochlearImplantMrsDay.jpgSEATTLE, Oct. 9, 2012 - On Tuesday, Oct. 2, Eleanor Day, 79, underwent a cochlear implant procedure at Swedish/Cherry Hill by Dr. Douglas Backous, medical director of the Center for Hearing and Skull Base Surgery. Her procedure was the world’s first live-instagrammed and live-tweeted cochlear implant (hearing restoration) surgery (click here to see a recap). This Wednesday, Oct. 10, Swedish will live stream Mrs. Day’s cochlear implant activation, in which she will potentially hear her husband’s voice without the help of hearing aids for the first time in five years. The Days have been married for 60 years.

Swedish-Affiliated Neurologist Interviewed about Results of New Study on 'Mini' Strokes and Clot-Busting Drugs

Swedish News

SEATTLE, Oct. 8, 2012 - A short video news story on new research around the use of clot-busting dugs to treat 'mini' strokes was recently posted on the national news sites EverydayHealth.com and AOL.com. The two-minute long piece features an interview with William Likosky, M.D., medical director of Swedish Neuroscience Institute's Stroke Program, as well as a local stroke patient.

Swedish to Host World’s First Live-Instagrammed, Live-Tweeted Hearing Restoration Surgery as Part of Month-Long Educational Web Series on Hearing Loss

Swedish News

SEATTLE, Sept. 26, 2012 - Swedish Medical Center and Douglas Backous, M.D., medical director of the Center for Hearing and Skull Base Surgery at the Swedish Neuroscience Institute, will host the world’s first live-instagrammed and live-tweeted cochlear implant (hearing restoration) surgery on Tuesday, Oct. 2 at 7 a.m. Pacific Time (PT).

Swedish Contributes to New Treatment Option for Multiple Sclerosis

Pavle Repovic, MD, PhD

 On September 12, 2012, the Food and Drug Administration (FDA) approved teriflunomide for the treatment of multiple sclerosis (MS). Teriflunomide (AUBAGIO) is a once-daily pill for the treatment of relapsing forms of MS. Led by Dr. Lily Jung Henson, the Swedish Neuroscience Institute was among several clinical sites that tested the drug. Results of the research showed that teriflunomide can lessen MS disease activity. Specifically, it behaves similarly to injectable therapies by slowing MS relapse frequency, the rate of disability and MRI activity.

The safety profile, however, is more challenging than ....

Taking Control of Your Brain Health: Class is Sept. 29 at Swedish/Issaquah

Natalie Kozimor

First you can’t remember where you left your keys. Then an acquaintance’s name just won’t come to you.

Is it just old age or is it a memory disorder? Sometimes it’s hard to tell and not knowing can be equally as frustrating as forgetfulness itself.

The best way to head off memory loss and to figure out if that is in fact what you’re experiencing is to talk with your doctor and discuss your concerns. Of course, it’s not always easy or convenient to get to the doctor. Dr. Lily Jung-Henson, of the Swedish Neuroscience Institute, holds free community classes that cover these issues and allow you the chance to get some of your questions answered.

Partnering with Dr. Arpan Waghray, Medical Director for Behavioral Health at Swedish, and other members of the Swedish Rehab Services team in Issaquah, Dr. Jung-Henson will be holding a class called “Taking Control of Your Brain Health” on Saturday, September 29.

This free class will be held at the Swedish/Issaquah hospital in the Highlands from 10:30 a.m. to 12:30 p.m. and will help you answer questions such as:

Results 71-77 of 100

More information about the Swedish newsroom

Explore the rest of the Swedish blog

Swedish has a social media policy

See who is blogging at Swedish

   Keep up with Swedish:

    Check out the Swedish blog

Find a Physician

              Subscribe to
             HealthWatch